Differential effects of androgens and estrogens on bone turnover in normal men

被引:200
作者
Leder, BZ
LeBlanc, KM
Schoenfeld, DA
Eastell, R
Finkelstein, JS
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Biostat, Dept Med, Boston, MA 02114 USA
[3] No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
10.1210/jc.2002-021036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The physiologic role of androgens and estrogens in the maintenance of normal bone turnover in men is a fundamental issue in bone biology. To address this question, we randomized 70 men between the ages of 20 and 44 yr to receive one of three treatment regimens. Group 1 (n = 25) received a GnRH analog (goserelin acetate 3.6 mg by se injection every 4 wk) alone for 12 wk to suppress endogenous gonadal steroids to prepubertal levels. Group 2 (n = 22) received goserelin plus transdermal testosterone (Androderm 5 mg topically daily) to normalize circulating testosterone and estradiol levels. Group 3 (n = 23) received goserelin plus testosterone plus an aromatase inhibitor (anastrozole 1 mg orally daily) to induce selective estrogen deficiency. The selective effects of androgens and estrogens on skeletal homeostasis were then assessed by measuring changes in biochemical markers of bone turnover and analyzing the between-group differences. Bone resorption markers increased in both the hypogonadal group (group 1) and in the group with selective estrogen deficiency (group 3). Urinary deoxypyridinoline excretion increased more in group 1 than in group 3 (P = 0.023), suggesting a significant effect of androgens on bone resorption, whereas serum N-telopeptide levels increased more in group 3 than in group 2 (P = 0.037), suggesting a significant effect of estrogen on bone resorption. Bone formation markers initially declined in all groups and then increased in groups 1 and 3. The between-group comparisons were consistent for all formation markers. Bone formation markers increased more in group 1 than in group 2 (P = 0.001, 0.037, 0.005 for osteocalcin, carboxyterminal propeptide of type I procollagen, and amino-terminal propeptide of type I procollagen, respectively). Bone formation markers also increased more in group I than in group 3 but these differences were not statistically significant (P = 0.065 0.073, 0.099 for osteocalcin, carboxy-terminal propeptide of type I procollagen, and amino-terminal propeptide of type I procollagen, respectively). Taken together, these data suggest that both androgens and estrogens play independent and fundamental roles in regulating bone resorption in men. These data also suggest that androgens may play an important role in the regulation of bone formation in men.
引用
收藏
页码:204 / 210
页数:7
相关论文
共 41 条
[11]   Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men [J].
Falahati-Nini, A ;
Riggs, BL ;
Atkinson, EJ ;
O'Fallon, WM ;
Eastell, R ;
Khosla, S .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) :1553-1560
[12]   Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study [J].
Greendale, GA ;
Edelstein, S ;
BarrettConnor, E .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (11) :1833-1843
[13]   Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro [J].
Kasperk, CH ;
Wakley, GK ;
Hierl, T ;
Ziegler, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (03) :464-471
[14]   ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE-CELLS INVITRO [J].
KASPERK, CH ;
WERGEDAL, JE ;
FARLEY, JR ;
LINKHART, TA ;
TURNER, RT ;
BAYLINK, DJ .
ENDOCRINOLOGY, 1989, 124 (03) :1576-1578
[15]   DIETARY CALCIUM, SEX-HORMONES, AND BONE-MINERAL DENSITY IN MEN [J].
KELLY, PJ ;
POCOCK, NA ;
SAMBROOK, PN ;
EISMAN, JA .
BRITISH MEDICAL JOURNAL, 1990, 300 (6736) :1361-1364
[16]   Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men [J].
Khosla, S ;
Melton, LJ ;
Atkinson, EJ ;
O'Fallon, WM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3555-3561
[17]   Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen [J].
Khosla, S ;
Melton, LJ ;
Atkinson, EJ ;
O'Fallon, WM ;
Klee, GG ;
Riggs, BL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2266-2274
[18]   Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity [J].
Kousteni, S ;
Bellido, T ;
Plotkin, LI ;
O'Brien, CA ;
Bodenner, DL ;
Han, L ;
Han, K ;
DiGregorio, GB ;
Katzenellenbogen, JA ;
Katzenellenbogen, BS ;
Roberson, PK ;
Weinstein, RS ;
Jilka, RL ;
Manolagas, SC .
CELL, 2001, 104 (05) :719-730
[19]   Two different pathways for the maintenance of trabecular bone in adult male mice [J].
Lindberg, MK ;
Movérare, S ;
Skrtic, S ;
Alatalo, S ;
Halleen, J ;
Mohan, S ;
Gustafsson, JÅ ;
Ohlsson, C .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (04) :555-562
[20]   ORIGIN OF ESTROGEN IN NORMAL MEN AND IN WOMEN WITH TESTICULAR FEMINIZATION [J].
MACDONALD, PC ;
MADDEN, JD ;
BRENNER, PF ;
WILSON, JD ;
SIITERI, PK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (06) :905-916